These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6170321)

  • 41. Redox potential-pH properties of the flavoprotein L-amino-acid oxidase.
    Stankovich MT; Fox BG
    Biochim Biophys Acta; 1984 Apr; 786(1-2):49-56. PubMed ID: 6712956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of sulfur dioxide in grapes and wines.
    Ough CS
    J Assoc Off Anal Chem; 1986; 69(1):5-7. PubMed ID: 3949701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemistry of bleomycin. XIX Revised structures of bleomycin and phleomycin.
    Takita T; Muraoka Y; Nakatani T; Fujii A; Umezawa Y; Naganawa H
    J Antibiot (Tokyo); 1978 Aug; 31(8):801-4. PubMed ID: 80403
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter: The chemistry of bleomycin X. The stereochemistry and crystal structure of beta-hydroxyhistidine, an amine component of bleomycin.
    Koyama G; Nakamura H; Muraoka Y; Takita T; Maeda K
    J Antibiot (Tokyo); 1973 Feb; 26(2):109-11. PubMed ID: 4131158
    [No Abstract]   [Full Text] [Related]  

  • 45. Energy dependence of oxidation-reduction potentials of the b and c cytochromes in beef heart submitochondrial particles.
    Dutton PL; Wilson DF; Lee CP
    Biochem Biophys Res Commun; 1971 Jun; 43(5):1186-91. PubMed ID: 5568186
    [No Abstract]   [Full Text] [Related]  

  • 46. Copper(II)- and iron(II)-complexes of methyl 2-(2-aminoethyl)-aminomethyl-pyridine-6-carboxyl-histidinate (AMPHIS), a peptide mimicking the metal-chelating moiety of bleomycin. An ESR investigation.
    Hénichart JP; Bernier JL; Houssin R; Lohez M; Kenani A; Catteau JP
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1036-41. PubMed ID: 2579645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Copper(II).bleomycin, iron(III).bleomycin, and copper(II).phleomycin: comparative study of deoxyribonucleic acid binding.
    Povirk LF; Hogan M; Dattagupta N; Buechner M
    Biochemistry; 1981 Feb; 20(3):665-71. PubMed ID: 6163448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quenching of fluorescence of bleomycins by ferrous ion and its correlation with DNA-breakage activity.
    Huang CH; Galvan L; Crooke ST
    Biochemistry; 1979 Jun; 18(13):2880-7. PubMed ID: 89865
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemistry of bleomycin. XVII. Chemical proof for the beta-lactam of bleomycin.
    Muraoka Y; Fuji A; Yoshioka T; Takita T; Umezawa H
    J Antibiot (Tokyo); 1977 Feb; 30(2):178-81. PubMed ID: 66228
    [No Abstract]   [Full Text] [Related]  

  • 50. ESR of copper and iron complexes with antitumor and cytotoxic properties.
    Antholine WE; Kalyanaraman B; Petering DH
    Environ Health Perspect; 1985 Dec; 64():19-35. PubMed ID: 2420582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metal binding to modified bleomycins. Zinc and ferrous complexes with an acetylated bleomycin.
    Oppenheimer NJ; Rodriguez LO; Hecht SM
    Biochemistry; 1980 Aug; 19(17):4096-103. PubMed ID: 6157406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA breaks generated by the bleomycin-iron III complex in the presence of KHSO5, a single oxygen donor.
    Pratviel G; Bernadou J; Meunier B
    Biochem Biophys Res Commun; 1986 May; 136(3):1013-20. PubMed ID: 2424435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxidative titration of monomolecular films of cytochrome c-II and of bacteriochlorophyll.
    Reinach P; Brody SS
    Biochemistry; 1972 Jan; 11(1):92-6. PubMed ID: 5009438
    [No Abstract]   [Full Text] [Related]  

  • 54. Chemistry of bleomycin. XXIV. Deadmido bleomycin from viewpoint of metal coordination and oxygen activation.
    Sugiura Y; Muraoka Y; Fujii A; Takita T; Umezawa H
    J Antibiot (Tokyo); 1979 Jul; 32(7):756-8. PubMed ID: 94326
    [No Abstract]   [Full Text] [Related]  

  • 55. Oxidation-reduction potential studies: a new method in pharmacology principles, materials, and methods.
    Rouillon JD; Bernard C; Robert G; Magnin P
    J Pharmacol Methods; 1987 Apr; 17(2):179-84. PubMed ID: 3586691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Redox activation of Fe(III)-thiosemicarbazones and Fe(III)-bleomycin by thioredoxin reductase: specificity of enzymatic redox centers and analysis of reactive species formation by ESR spin trapping.
    Myers JM; Cheng Q; Antholine WE; Kalyanaraman B; Filipovska A; Arnér ES; Myers CR
    Free Radic Biol Med; 2013 Jul; 60():183-94. PubMed ID: 23485585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new Salmonella tester strain (TA102) with A X T base pairs at the site of mutation detects oxidative mutagens.
    Levin DE; Hollstein M; Christman MF; Schwiers EA; Ames BN
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7445-9. PubMed ID: 6760198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bleomycin-detectable iron in knee-joint synovial fluid from arthritic patients and its relationship to the extracellular antioxidant activities of caeruloplasmin, transferrin and lactoferrin.
    Gutteridge JM
    Biochem J; 1987 Jul; 245(2):415-21. PubMed ID: 2444216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Superoxide dismutase and Fenton chemistry. Reaction of ferric-EDTA complex and ferric-bipyridyl complex with hydrogen peroxide without the apparent formation of iron(II).
    Gutteridge JM; Maidt L; Poyer L
    Biochem J; 1990 Jul; 269(1):169-74. PubMed ID: 2165392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Redox potential of iron-bleomycin.
    Melnyk DL; Horwitz SB; Peisach J
    Biochemistry; 1981 Sep; 20(18):5327-31. PubMed ID: 6170321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.